[1] LIN C J, XIAO W X, FU T, et al. Calcifications in triple-negative breast cancer: molecular features and treatment strategies[J]. NPJ Breast Cancer, 2023, 9(1): 26. [2] HUSSAIN S, DURRANI F, KHAN A. Frequency and clinicopathologic characteristics of triple-negative breast cancer among breast cancer patients presenting to medical oncology department, hayatabad medical complex Peshawar, Pakistan[J]. Cureus, 2023, 15(2): e34581. [3] ZHANG Y L, LIU Q F, LIAO Q. CircHIPK3: a promising cancer-related circular RNA[J]. Am J Transl Res, 2020, 12(10): 6694-6704. [4] XIE Y M, YUAN X F, ZHOU W M, et al. The circular RNA HIPK3(circHIPK3) and its regulation in cancer progression: review[J]. Life Sci, 2020, 254: 117252. [5] 丛佳, 石杨, 刘远远. 环状RNA同源域相互作用蛋白激酶3促进三阴乳腺癌细胞增殖和迁移的作用机制研究[J]. 实用临床医药杂志, 2022, 26(13): 93-99. [6] SANTOLLA M F, TALIA M, MAGGIOLINI M. S100A4 is involved in stimulatory effects elicited by the FGF2/FGFR1 signaling pathway in triple-negative breast cancer (TNBC) cells[J]. Int J Mol Sci, 2021, 22(9): 4720. [7] WU S S, LIU S M, SONG H H, et al. Circular RNA HIPK3 plays a carcinogenic role in cervical cancer progression via regulating miR-485-3p/FGF2 axis[J]. J Investig Med, 2021, 69(3): 768-774. [8] LAI J J, XIN J, FU C D, et al. CircHIPK3 promotes proliferation and metastasis and inhibits apoptosis of renal cancer cells by inhibiting miR-485-3p[J]. Cancer Cell Int, 2020, 20: 248. [9] LIN S C, LIU C, TAO Z H, et al. Clinicopathological characteristics and survival outcomes in breast carcinosarcoma: a SEER population-based study[J]. Breast, 2020, 49: 157-164. [10] LV Y, MA X, DU Y X, et al. Understanding patterns of brain metastasis in triple-negative breast cancer and exploring potential therapeutic targets[J]. Onco Targets Ther, 2021, 14: 589-607. [11] WARREN L E G, NIMAN S M, REMOLANO M C, et al. Incidence, characteristics, and management of central nervous system metastases in patients with inflammatory breast cancer[J]. Cancer, 2022, 128(23): 4085-4094. [12] LIAN Q X, SONG Y, HAN L L, et al. Development of a circHIPK3-based CeRNA network and identification of mRNA signature in breast cancer patients harboring BRCA mutation[J]. PeerJ, 2023, 11: e15572. [13] LUO N, LIU S Q, LI X, et al. Circular RNA circHIPK3 promotes breast cancer progression via sponging miR-326[J]. Cell Cycle, 2021, 20(13): 1320-1333. [14] YAO D, LIN S C, CHEN S Z, et al. circHIPK3 regulates cell proliferation and migration by sponging microRNA-124 and regulating serine/threonine kinase 3 expression in esophageal squamous cell carcinoma[J]. Bioengineered, 2022, 13(4): 9767-9780. [15] ZHANG H B, DAI Q, ZHENG L H, et al. Knockdown of circHIPK3 inhibits tumorigenesis of hepatocellular carcinoma via the miR-582-3p/DLX2 axis[J]. Biochem Biophys Res Commun, 2020, 533(3): 501-509. [16] LIU F C, FAN Y R, OU L P, et al. CircHIPK3 facilitates the G2/M transition in prostate cancer cells by sponging miR-338-3p[J]. Onco Targets Ther, 2020, 13: 4545-4558. [17] LI D D, XIA L Y, HUANG P, et al. Cancer-associated fibroblast-secreted IGFBP7 promotes gastric cancer by enhancing tumor associated macrophage infiltration via FGF2/FGFR1/PI3K/AKT axis[J]. Cell Death Discov, 2023, 9(1): 17. [18] HE Q M, REN X Y, CHEN J W, et al. MiR-16 targets fibroblast growth factor 2 to inhibit NPC cell proliferation and invasion via PI3K/AKT and MAPK signaling pathways[J]. Oncotarget, 2016, 7(3): 3047-3058. |